logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

美股牛市支柱动摇,企业盈利成中流砥柱

Medline’s Stock Price Soars After Market Debut, Wall Street Bullish on the “Aging Dividend”

Jan 12, 2026

Life Science

Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley

Can Obesity Drug Dark Horse GPCR Double Its Stock Price Again in 2026?

Jan 11, 2026

Life Science

避险需求助推金价上涨,黄金类资产投资价值凸显

Amazon Pharmacy Launches Oral Wegovy Sales, Presenting New Opportunity for Novo Nordisk 

Jan 9, 2026

Life Science

The Case for Brookfield Renewable Amidst Trump’s 100% Tariff Talk

A Trump Tariff Victory? U.S. Trade Gap Nosedives, But Economists See a Mirage

Jan 8, 2026

Life Science, Precious Metals

Hims & Hers Stock Plunges 25% After Abandoning Copycat Wegovy Pill

Can CVS Health and Amgen Continue Their Winning Streak in 2026?

Jan 8, 2026

Life Science

获亿万富翁重仓押注,梯瓦制药业绩与管线双驱动

Outlook for the U.S. Stock Market Healthcare Sector in 2026: Three Major Trends Reshaping Investment Logic

Jan 8, 2026

Life Science

Finding Value in a High-Priced Market: 6 Stocks for 2026

Finding Value in a High-Priced Market: 6 Stocks for 2026

Jan 7, 2026

Consumer Goods, Life Science, Technology

Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio

Jan 7, 2026

Life Science

The Federal Government’s $21 Billion Bet: Semiconductors, Rare Earths, and a New Kind of Industrial Policy

What Eli Lilly Offers Investors as It Nears a $1 Trillion Valuation

Jan 6, 2026

Life Science

美政府促成减肥药历史性降价,协议定价245美元

Analysts Optimistic About Prospects, UnitedHealth Group Stock Gets a Boost

Jan 6, 2026

Life Science

木头姐2026布局转向,重仓基因编辑技术

Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology

Jan 5, 2026

Life Science

诺和诺德首发口服减肥药,百亿美元市场格局生变

Novo Nordisk Launches Oral Weight-Loss Drug, Shifting the $100 Billion Market Landscape

Jan 5, 2026

Life Science

Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion

Nektar Therapeutics Too Risky? This Biotech Stock Offers a Safer Bet

Jan 5, 2026

Life Science

Defense Tech Heat Check: PSN, LDOS, BAH, CACI, SAIC

Jan 5, 2026

Life Science

Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest

Is Pfizer Stock, Now Under $25, a Buy?

Jan 1, 2026

Life Science

为什么这两只成长股能在2031年前持续跑赢大盘?

Why Can These Two Growth Stocks Continue to Outperform the Market Until 2031?

Dec 31, 2025

Life Science, Technology

股价上涨1323%之后,英伟达的下一个驱动力?

Eli Lilly Plans to Acquire Abivix, Could This Deal Become a New Growth Engine?

Dec 31, 2025

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Bristol-Myers Squibb Bets on the Future, Which Pipelines Will Become the New Pillars of Growth? 

Dec 30, 2025

Life Science

  • ‹‹ Previous
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada